(Q64361014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Clinical and therapeutic aspects of AA amyloidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

van Rijswijk MH

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

Bailliere's clinical rheumatology

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

661-690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Subclinical adrenocortical insufficiency in renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

A clinical analysis of the course and prognosis of forty-two patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Hepatic amyloidosis: morphologic differences between systemic AL and AA types

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Resolution of nephrotic syndrome and lack of progression of heroin-associated renal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Secondary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloidosis in the rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Secondary localized amyloidosis in interstitial keratitis. Clinicopathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

X-ray diffraction studies on amyloid filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Immunohistological characterisation of amyloid deposits in renal biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Xanthogranulomatous pyelonephritis and amyloidosis: a rare association.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Beta 2-microglobulin-associated amyloidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Hyposplenism in primary systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Deposition of amyloid in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

A primed state exists in vivo following histological regression of amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

AMYLOIDOSIS: ITS DIFFERENTIATION INTO PERIRETICULIN AND PERI-COLLAGEN TYPES

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloid localized to tenosynovium at carpal tunnel release. Natural history of 124 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Synovial fluid analysis for diagnosis of amyloid arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Intestinal pseudo-obstruction in systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Remission of nephrotic syndrome related to AA amyloidosis after hepatic adenomectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloid deposits in lymph nodes: a morphologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Hepatic amyloidosis in intravenous drug abusers and AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Regression of amyloidosis secondary to rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Renal transplantation in 45 patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Renal amyloidosis secondary to acne conglobata

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Diffuse interstitial lung disease due to AA amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Localized pleural microdeposition of type A amyloid in a patient with rheumatoid pleuritis. Histologic distinction from pleural involvement in systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Familial Mediterranean fever. A survey of 470 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Chemical heterogeneity of amyloid in the carpal tunnel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Barium meal study for amyloidosis of the small intestine: measurements on radiograph

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

The expanding spectrum of a disease. Behçet's disease associated with amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

PATHOGENESIS OF AMYLOIDOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Amyloidosis--incidence and early risk factors in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Dimethyl sulfoxide in the treatment of AA amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Ueber eine im Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

The heterogeneity of protein AA in secondary (reactive)systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Massive vascular AA-amyloidosis: a histologically and biochemically distinctive subtype of reactive systemic amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

A genetic marker for systemic amyloidosis in juvenile arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980121-9

7 January 2021

10.1016/S0950-3579(05)80121-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954868%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference